Print

Endovasc Inc. (EVSC) Announces Completion Of Liprostin Manufacturing For Phase IIIa Trial  
9/6/2006 11:01:21 AM

HOUSTON--(BUSINESS WIRE)--Sept. 6, 2006--ENDOVASC INC. (OTCBB:EVSC), today announced that PYRAMID Laboratories, Inc. has completed the cGMP manufacturing of Liprostin for the Company's proposed phase IIIa clinical trial for patients suffering from Intermittent Claudication.
//-->